JMJD6 and lung cancer: Notably, targeting JMJD6 may provide additional ways to treat lung cancer, since suppressing JMJD6 via acetylating its upstream transcriptional factor HOXB9 resulted in a decrease in tumor growth and migration in xenograft models [138].